ERRATUM article

Front. Pharmacol., 19 December 2024

Sec. Ethnopharmacology

Volume 15 - 2024 | https://doi.org/10.3389/fphar.2024.1539089

Erratum: Triterpenoids from Ganoderma lucidum inhibit cytochrome P450 enzymes interfering with the metabolic process of specific clinical drugs

  • FP

    Frontiers Production Office

  • Frontiers Media SA, Lausanne, Switzerland

Due to a production error, the funders “National Natural Science Foundation of China (82374297), Dalian Science and Technology Leading Talents Project (2020RJ09), Dalian Science and Technology Innovation Fund (2023JJ12SN033)” to “Chao Wang”; and “Dalian Medical University Intensified Program of Wellness Interdisciplinary Research Cooperation Project Team Funding (JCHZ2023004)” to “Guixin Zhang” were erroneously removed. The corrected Funding statement is below:

Statements

Funding

The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. CW: National Natural Science Foundation of China (82374297), Dalian Science and Technology Leading Talents Project (2020RJ09), Dalian Science and Technology Innovation Fund (2023JJ12SN033). JZ: The Natural Science Foundation for Academic and Technical Leaders of Jiangxi Province (grant number 20212BCJ23026), 2023 National Training Program for Inheritance of Characteristic Techniques of Traditional Chinese Medicine (T20234832005), the Traditional Chinese Medicine Key Laboratory of Jiangxi Province (KP202203007), Traditional Chinese Medicine Science and Technology Plan of Jiangxi Provincial Health and Family Planning Commission (No. 2023B1319). GZ: Dalian Medical University Intensified Program of Wellness Interdisciplinary Research Cooperation Project Team Funding (JCHZ2023004).

The publisher apologizes for this mistake. The original article has been updated.

Summary

Keywords

Ganoderma lucidum, functional food, CYP450s, lanostrane triterpenoid, drug-drug interactions

Citation

Frontiers Production Office (2024) Erratum: Triterpenoids from Ganoderma lucidum inhibit cytochrome P450 enzymes interfering with the metabolic process of specific clinical drugs. Front. Pharmacol. 15:1539089. doi: 10.3389/fphar.2024.1539089

Received

03 December 2024

Accepted

03 December 2024

Published

19 December 2024

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

15 - 2024

Updates

Copyright

*Correspondence: Frontiers Production Office,

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics